Quality specifications and the assessment of the biochemical risk of atherosclerosis
- 2 August 2004
- journal article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 346 (1) , 55-64
- https://doi.org/10.1016/j.cccn.2004.02.034
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Preanalytic and Analytic Sources of Variations in C-reactive Protein Measurement: Implications for Cardiovascular Disease Risk AssessmentClinical Chemistry, 2003
- Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and PreventionCirculation, 2003
- Markers of Inflammation and Cardiovascular DiseaseCirculation, 2003
- Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular EventsNew England Journal of Medicine, 2002
- Analytical performance and clinical efficacy of three routine procedures for LDL cholesterol measurement compared with the ultracentrifugation–dextran sulfate–Mg2+ methodClinica Chimica Acta; International Journal of Clinical Chemistry, 2000
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine, 2000
- Low-density lipoprotein cholesterol can be chemically measured: A new superior methodJournal of Laboratory and Clinical Medicine, 1998
- C-Reactive Protein Adds to the Predictive Value of Total and HDL Cholesterol in Determining Risk of First Myocardial InfarctionCirculation, 1998
- Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6Hepatology, 1990
- Low-density lipoprotein subclass patterns and risk of myocardial infarctionJAMA, 1988